Chief Medical Information Officer (CMIO) - UN1120
Under the responsibility of the CEO, the Chief Medical Information Officer (CMIO) provides the necessary leadership to ensure that LIH’s information technology applications, platforms and infrastructure are fully integrated to support its research and translational strategy.The CMIO will also lead the creation of an integrated big data platform that will allow Luxembourg’s research community and national/international stakeholders to access integrated clinical and research data, as well as health insurance and social security data. The successful candidate will make sure that information technology and the use of artificial intelligence are as solid as to support and enable transformational system change, in close cooperation with other main key stakeholders, such as health-related government bodies and hospitals.
Laboratory Technician in Disease Modeling Screening Platform - YJK1120-
he Laboratory Technician will work onsetting up Disease Modeling Screening Platform (DMSP) in Luxembourg. Disease ModelingScreening platform is a core faciclity for translational research inLuxembourg. He/she will mainly work on early drugdiscovery project at Disease modeling Screening Platform (DMSP).
[Press release] Exposure to pollutants – what can the hair of children in Luxembourg tell us?
Launch of a study on the exposure to pollutants of children living in Luxembourg.
26 November 2020 11:00 AM
WEBINAR: Lecture series Cancer Research: "Targeting DNA repair: from basic biology to clinical trials"- Prof Thomas Helleday
PhD student in Immuno-Oncology - AM1120
To be part of the Neuro-Immunology Group (Head: Dr. A. Michelucci) within the Department of Oncolgy at the LIH, we are currently looking for a PhD student.
[Press release] Innovative machine-learning approach for future diagnostic advances in Parkinson’s disease
In a new study led by the Immune Systems Biology research group of the LIH Department of Infection and Immunity, researchers adopted a holistic machine-learning approach to elucidate how the interactions between neuronal mitochondria can serve as a powerful tool to distinguish nerve cells from Parkinson’s patients from those belonging to healthy subjects, thereby providing new insights in the pathogenesis, diagnosis and treatment of this neurodegenerative disorder. The results were published today in the renowned journal ‘Nature Partner Journals Systems Biology and Application’.
12 November 2020 11:00 AM
WEBINAR: Lecture series Cancer Research: "Mechanisms driving cell plasticity in the colorectal tumor microenvironment"- Prof Florian Greten
[Press release] Advancing personalised cancer treatment through patient “avatars”
The NORLUX Neuro-Oncology Laboratory at the LIH Department of Oncology (DONC), in collaboration with the Centre Hospitalier de Luxembourg (CHL), the Laboratoire National de Santé (LNS), the Luxembourg Centre for Systems Biomedicine (LCSB) of the University of Luxembourg and other international partners, established a large collection of patient-derived glioma organoids and xenograft models that mimic the specific features of patient brain tumours. These tools will allow the establishment of personalised drug efficacy studies, thus increasing the chances of success of clinical trials and improving clinical outcomes for patients. The findings were presented in a recent publication in the international peer-reviewed journal Acta Neuropathologica.
Administrative Assistant - Clinical Studies - AF1120
The administrative assistant will be part of the Clinical andEpidemiological Investigation Center (CIEC) group in the Department ofPopulation Health. He/She will support the clinical projects by recruiting potentialparticipants by phone, and in particular by explaining the objectives andprotocol of the Predi-COVID study (https://www.fnr.lu/predi-covid-study/) and by answering their questions. A comprehensive training will be provided.